Summit Therapeutics SMMT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$1.08B-388% | -$221.32M+64.0% | -$614.93M-681% | -$78.78M+11.1% | ||
| $146K+64.0% | $89K-55.1% | $198K-43.3% | $349K+5.8% | ||
| $732.42M+1,337% | $50.98M+261% | $14.11M+18.1% | $11.95M-6.7% | ||
| —— | —— | —— | -$4.13M-141% | ||
| $12.93M+8.8% | $11.88M— | —— | $4.82M-12.3% | ||
| -$4.87M-166% | $7.37M+304% | -$3.61M+29.3% | -$5.11M-4,811% | ||
| $82K— | —— | $0— | $0— | ||
| -$322.93M-127% | -$142.11M-85.1% | -$76.76M— | —— | ||
| $657K+373% | $139K+8.6% | $128K— | —— | ||
| $484.99M-28.7% | $680.03M+112% | $321.02M— | $0— | ||
| —— | $489.84M+135% | $208.17M— | —— | ||
| -$174.31M— | —— | —— | —— | ||
| $5.65M+107% | $2.74M— | —— | $100M— | ||
| $617.53M+52.5% | $404.84M+368% | $86.59M-86.0% | $620.24M+696% | ||
| —— | —— | —— | —— | ||
| —— | $33.76M+105% | -$624.82M-208% | $576.82M— | ||
| $7.01M— | —— | —— | —— | ||
| $146K+64.0% | $89K-55.1% | $198K-43.3% | $349K+5.8% | ||
| —— | —— | —— | —— | ||
| —— | $6.56M— | —— | —— | ||
| —— | —— | -$366K— | —— | ||
| —— | —— | —— | —— | ||
| $82K— | —— | $0— | $0— | ||
| -$4.87M-166% | $7.37M+304% | -$3.61M+29.3% | -$5.11M— | ||
| $484.99M-28.7% | $680.03M+112% | $321.02M— | $0— | ||
| —— | $489.84M+135% | $208.17M— | —— | ||
| $5.65M+107% | $2.74M+195% | $929K+133% | $399K— | ||
| —— | $598K— | —— | $0— | ||
| $291K— | —— | $0— | —— | ||
| -$323.59M-127% | -$142.25M-85.0% | -$76.89M— | —— | ||
| -$323.59M-127% | -$142.25M-85.0% | -$76.89M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Summit Therapeutics generate?
- Summit Therapeutics (SMMT) generated -$384.1M in operating cash flow over the trailing twelve months.
- What is Summit Therapeutics's free cash flow?
- After $480.0K of capital expenditures, Summit Therapeutics's free cash flow was -$384.5M over the trailing twelve months, down 121.4% year over year.
- Where does Summit Therapeutics's cash flow data come from?
- Every line is extracted from Summit Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.